Evidence map›Paper›PMID 24816902›Full record

Observational studyLung2014

The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.

Antoni Sicras-Mainar, Javier Rejas-Gutiérrez, Ruth Navarro-Artieda, Jordi Ibáñez-Nolla

Abstract readComparative StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Lung, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Structured Evaluation and Management of Patients with COPD in an Accredited Program.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.International journal of chronic obstructive pulmonary disease · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Antoni Sicras-MainarDirección de Planificación y Desarrollo Organizativo, Badalona Serveis Assistencials SA, Calle Gaietà Soler, 6-8 entlo, 08911, Badalona, Barcelona, Spain, asicras@bsa.cat.
Javier Rejas-Gutiérrez
Ruth Navarro-Artieda
Jordi Ibáñez-Nolla
Badalona Serveis Assistencials · ESHospital Universitari Germans Trias i Pujol · ESPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic obstructive pulmonary disease (COPD) is a prevalent condition mainly related to smoking, which is associated with a substantial economic burden. The purpose was to compare healthcare resource utilization and costs according to smoking status in patients with COPD in routine clinical practice.

methodsA retrospective cohort nested case-control study was designed. The cohort was composed of male and female COPD outpatients, 40 years or older, covered by the Badalona Serveis Assistencials (a health provider) health plan. Cases were current smokers with COPD and controls (two per case) were former smokers with COPD (at least 12 months without smoking), matched for age, sex, duration of COPD, and burden of comorbidity. The index date was the last visit recorded in the database, and the analysis was performed retrospectively on healthcare resource utilization data for the 12 months before the index date.

resultsA total of 930 COPD records were analyzed: 310 current and 620 former smokers [mean age 69.4 years (84.6 % male)]. Cases had more exacerbations, physician visits of any type, and drug therapies related to COPD were more common. As a consequence, current smokers had higher average annual healthcare costs: €3,784 (1,888) versus €2,302 (2,451), p < 0.001. This difference persisted after adjusting for severity of COPD.

conclusionsCurrent smokers with COPD had significantly higher use of healthcare resources, mainly COPD drugs and physician visits, compared with former smokers who had abstained for at least 12 months. As a consequence, current smokers had higher healthcare costs to the National Health System in Spain than ex-smokers.

Indexed as

Health Care CostsSmoking PreventionAbsenteeismAdultAgedAged, 80 and overComorbidityDrug CostsEfficiencyFemaleHealth ResourcesHumansMaleMiddle AgedNational Health ProgramsOffice Visits

Identifiers

PMID24816902
OpenAlexW2049603700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.